TOPLINE: Resecting the primary colon tumor before chemotherapy does not improve overall survival compared with chemotherapy alone in patients with metastatic colon cancer not amenable to […]

TOPLINE: Treatment modifications, such as dose reductions, schedule changes, or use of less toxic regimens, can improve how well older patients with advanced cancer and aging-related […]

As an avid student of myeloma clinical trial history, I greatly appreciate the groundwork laid by past efforts. All that hard work has helped ease my […]

TOPLINE: Bilateral oophorectomy significantly reduces the risk for early death from any cause in women with a pathogenic variant in the BRCA1/2 genes, new data confirm. […]

The US Food and Drug Administration (FDA) has granted new approvals for the use of amivantamab-vmjw (Rybrevant, Janssen Biotech, Inc.) in certain patients with locally advanced […]

LILLE, FRANCE — Patients with lung cancer who reside in polluted areas (ie, those affected by PM2.5, PM10, or nitrogen dioxide) have an additional 50% risk […]

Bone-modifying agents — most notably denosumab — are often prescribed to prevent skeletal-related complications in patients with metastatic castration-sensitive prostate cancer, but the drugs are not […]

TOPLINE: A new study suggests individualized MRI surveillance of the spine based on patients’ risk for progression after spine stereotactic body radiotherapy (SBRT) can optimize the […]

A simple prediction model developed with US and European cohorts shows accuracy in identifying patients with relapsed/refractory multiple myeloma (RRMM) who are or are not at […]